about
Platelet function in hairy-cell leukaemia.Blasts from the pastLeukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factorViral hepatitis and tests for the Australia (hepatitis-associated) antigen and antibodyPlatelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrCalcium modulates the generation of inositol 1,3,4-trisphosphate in human platelets by the activation of inositol 1,4,5-trisphosphate 3-kinaseInositol lipids, phosphatidate and diacylglycerol share stearoylarachidonoylglycerol as a common backbone in thrombin-stimulated human plateletsCyclic AMP does not inhibit collagen-induced platelet signal transductionEvidence that adhesion of electrically permeabilized platelets to collagen is mediated by guanine nucleotide regulatory proteinsCytosolic calcium as a second messenger for collagen-induced platelet responses.Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.PLATELET SEQUESTRATION IN MAN. II. IMMUNOLOGICAL AND CLINICAL STUDIES.Thrombopoietin and platelet production in chronic immune thrombocytopenia.Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets.Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists.Blood platelet kinetics and platelet transfusionCGS 12970: a novel, long acting thromboxane synthetase inhibitorImmune thrombocytopenic purpura: autoimmune or immune complex disease?Treatment of idiopathic thrombocytopenic purpura with ascorbate.The pathogenesis of immune thrombocytopenic purpura.Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP).Platelet sequestration studies in man.May-Hegglin anomaly: a defect in megakaryocyte fragmentation?Platelet function: a review. II. Abnormal function.Neuraminidase-induced thrombocytopenia in rats.Antimetastatic effects associated with platelet reduction.Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival.Acute complement-mediated haemolysis in the rabbit: relationship between the thrombocytopenia and neutropenia and complement consumption.Studies of platelet production and sequestration in the experimental animal.Sites of platelet destruction in idiopathic thrombocytopenic purpura.Familial thrombocytopenic thrombocytopathy.Regulation of platelet production: "thrombopoietin".Antibodies against platelet membrane glycoproteins. II. Influence on ADP- and collagen-induced platelet aggregation, crossed immunoelectrophoresis studies and relevance to Glanzmann's thrombasthenia.Platelet-associated complement C3 in thrombocytopenic states.Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteinsPlatelet survival and platelet production in systemic lupus erythematosus (SLE).Plasma levels of platelet factor 4 measured by radioimmunoassay.Pharmacological differentiation by pertussis toxin of the in vivo acute responses to fMLP and PAF in guinea-pig lungs.Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy.
P2860
Q24529185-176F5CEA-7402-4602-8B9F-2CA9E7579C9DQ24563415-C0053DE5-E538-40A3-9E42-D60756568E80Q24679152-D9C0A943-54AE-4A7D-9190-E89706091C74Q27486291-A761ACE7-4079-428D-AD48-D7B6AAABD551Q28211186-461C34FF-5FA1-4A9F-8C5F-17A5AEF40F1CQ28359862-E29CF806-891E-4066-98A4-489B265A59D0Q28366835-32D0E288-2DDD-448D-92CC-030B3447FE94Q33190198-887F3E21-C814-40E6-A89A-E2EED05B18F4Q33192004-BD123E9E-36E0-4E79-8360-024409A6771EQ33196761-D64E1C9B-C701-43F4-BCD4-95B45EE3D6BDQ33332522-A181D936-4FF8-474E-BD38-ED3ADECEB6E4Q33355159-EFFEC157-78C1-4AED-84F4-92856F2A60F5Q33387153-F36412CD-18A4-428C-935C-C353907B7736Q33397149-24A05665-A28B-4B1E-A826-B71B30E2DB0DQ33402843-1EDEFD7B-D12C-4D47-A668-5DDD3010D331Q33411231-B799072C-1F50-4A71-811D-6FDE050DD31CQ33444531-13AAAD45-F2CF-4484-8B5C-3606362E051AQ33444664-50FB95B3-7A4E-46F4-962B-92FDA0C3455BQ33448500-6243D5CE-86D6-4380-B927-F56D70C67B33Q33450800-0165BFF2-30A9-4D27-9A15-9A053CAA3933Q33462239-47FE3C09-0DAD-4712-9C10-966EC571A42BQ33464718-2CEBB302-F125-4291-BCC7-FF9FCB887B6DQ33467026-C8E2786A-7905-4102-9E47-32F88038FCE9Q33467509-53E84F44-714C-486C-8BD3-B2AF3C20DD24Q33468353-9DCF3D2A-77D1-4DDF-9EB3-C0FC55FFC587Q33469561-8213A8F6-1134-4C26-9B86-8C795DB1900FQ33470082-E52A875E-CF30-437E-8474-0926D7D3E0B7Q33470137-293E7518-D79B-4EFA-BE35-D449EB91775AQ33470997-4D96BFAA-FEFB-4409-A5C6-305FD64808E8Q33472625-4415DB9D-9BC7-47BB-93DB-0ADB5308E55BQ33474006-0EE737C8-5363-4FBB-BE9E-144BA5254C13Q33475162-EFA7328D-52E0-4050-BC54-135AB5691CA1Q33475170-0AB56418-E38A-4C04-8ACD-4165D92B16ECQ33478542-16C56865-4014-4C30-B6DF-5A07FA4E0B61Q33479812-9A1524B8-79BE-4E54-8128-A45FF08BDA57Q33483955-B750EB38-467D-4FC9-B50A-56010EC99271Q33487318-34CCE138-5F1F-452D-8F0A-DC927D8171BCQ33487690-BF941631-F5F6-4311-BD49-2C8B3BD8F56AQ33494464-D9CB8728-6ED0-4E9D-933E-73004852C073Q33552247-D6E38075-658D-41C7-8E7A-FD1FFE9A9272
P2860
description
1964 nî lūn-bûn
@nan
1964 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
PLATELET SEQUESTRATION IN MAN. I. METHODS.
@ast
PLATELET SEQUESTRATION IN MAN. I. METHODS.
@en
type
label
PLATELET SEQUESTRATION IN MAN. I. METHODS.
@ast
PLATELET SEQUESTRATION IN MAN. I. METHODS.
@en
prefLabel
PLATELET SEQUESTRATION IN MAN. I. METHODS.
@ast
PLATELET SEQUESTRATION IN MAN. I. METHODS.
@en
P2860
P356
P1476
PLATELET SEQUESTRATION IN MAN. I. METHODS.
@en
P2093
P2860
P304
P356
10.1172/JCI104970
P407
P577
1964-05-01T00:00:00Z